Dr. Koustenis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11700 N Meridian Street
Carmel, IN 46032
Education & Training
- Indiana University School of MedicineClass of 2019
Certifications & Licensure
- IN State Medical License 2023 - 2025
- KY State Medical License 2020 - 2023
Publications & Presentations
PubMed
- 431 citationsMONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast CancerMaura N. Dickler, Sara M. Tolaney, Hope S. Rugo, Javier Cortes, Véronique Diéras
Clinical Cancer Research. 2017-09-01 - 293 citationsPROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally A...Suresh Senan, Anthony Brade, Lu Hua Wang, Johan Vansteenkiste, Shaker R. Dakhil
Journal of Clinical Oncology. 2016-09-19 - 10 citationsSingle agent VS-6766 or VS-6766 plus defactinib in-mutant non-small-cell lung cancer: the RAMP-202 phase II trial.Enrica Capelletto, Paolo Bironzo, Louis Denis, Andrew Koustenis, Maristella Bungaro
Future Oncology. 2022-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: